Integra Lifesciences Holdings Current Cash

Integra Lifesciences Holdings (IART) currently reports a current cash of $210M as of June 2026. That compares with $220M in the prior-year period — down 1.6% year over year. Use the charts on this page to explore Integra Lifesciences Holdings's current cash history and peer comparisons.

Integra Lifesciences Holdings's current cash decreased from $220M to $210M — a 1.6% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Integra Lifesciences Holdings reported $210M in current cash as of June 2026. That compares with $220M in the prior-year period — down 1.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $210M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Integra Lifesciences Holdings, and consider following IART for alerts when major investors trade the stock.

Integra Lifesciences Holdings is classified in the Healthcare sector. On current cash, it currently shows $210M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IART with unrelated industries.